id	sid	tid	token	lemma	pos
8w32r496w7k	1	1	asthma	asthma	NOUN
8w32r496w7k	1	2	is	be	AUX
8w32r496w7k	1	3	a	a	DET
8w32r496w7k	1	4	chronic	chronic	ADJ
8w32r496w7k	1	5	pulmonary	pulmonary	ADJ
8w32r496w7k	1	6	disease	disease	NOUN
8w32r496w7k	1	7	that	that	PRON
8w32r496w7k	1	8	affects	affect	VERB
8w32r496w7k	1	9	over	over	ADP
8w32r496w7k	1	10	150	150	NUM
8w32r496w7k	1	11	million	million	NUM
8w32r496w7k	1	12	people	people	NOUN
8w32r496w7k	1	13	worldwide	worldwide	ADV
8w32r496w7k	1	14	and	and	CCONJ
8w32r496w7k	1	15	over	over	ADP
8w32r496w7k	1	16	17	17	NUM
8w32r496w7k	1	17	million	million	NUM
8w32r496w7k	1	18	in	in	ADP
8w32r496w7k	1	19	the	the	DET
8w32r496w7k	1	20	united	united	PROPN
8w32r496w7k	1	21	states	states	PROPN
8w32r496w7k	1	22	alone	alone	ADV
8w32r496w7k	1	23	.	.	PUNCT
8w32r496w7k	2	1	in	in	ADP
8w32r496w7k	2	2	asthma	asthma	NOUN
8w32r496w7k	2	3	,	,	PUNCT
8w32r496w7k	2	4	chronic	chronic	ADJ
8w32r496w7k	2	5	inflammation	inflammation	NOUN
8w32r496w7k	2	6	causes	cause	VERB
8w32r496w7k	2	7	an	an	DET
8w32r496w7k	2	8	associated	associated	ADJ
8w32r496w7k	2	9	increase	increase	NOUN
8w32r496w7k	2	10	in	in	ADP
8w32r496w7k	2	11	airway	airway	NOUN
8w32r496w7k	2	12	hyperresponsiveness	hyperresponsiveness	NOUN
8w32r496w7k	2	13	that	that	PRON
8w32r496w7k	2	14	leads	lead	VERB
8w32r496w7k	2	15	to	to	ADP
8w32r496w7k	2	16	recurrent	recurrent	ADJ
8w32r496w7k	2	17	episodes	episode	NOUN
8w32r496w7k	2	18	of	of	ADP
8w32r496w7k	2	19	wheezing	wheezing	NOUN
8w32r496w7k	2	20	,	,	PUNCT
8w32r496w7k	2	21	breathlessness	breathlessness	NOUN
8w32r496w7k	2	22	,	,	PUNCT
8w32r496w7k	2	23	chest	chest	NOUN
8w32r496w7k	2	24	tightness	tightness	NOUN
8w32r496w7k	2	25	,	,	PUNCT
8w32r496w7k	2	26	and	and	CCONJ
8w32r496w7k	2	27	coughing	cough	VERB
8w32r496w7k	2	28	,	,	PUNCT
8w32r496w7k	2	29	particularly	particularly	ADV
8w32r496w7k	2	30	at	at	ADP
8w32r496w7k	2	31	night	night	NOUN
8w32r496w7k	2	32	or	or	CCONJ
8w32r496w7k	2	33	in	in	ADP
8w32r496w7k	2	34	the	the	DET
8w32r496w7k	2	35	early	early	ADJ
8w32r496w7k	2	36	morning	morning	NOUN
8w32r496w7k	2	37	(	(	PUNCT
8w32r496w7k	2	38	ref	ref	PROPN
8w32r496w7k	2	39	.	.	PUNCT
8w32r496w7k	3	1	2	2	X
8w32r496w7k	3	2	)	)	PUNCT
8w32r496w7k	3	3	.	.	PUNCT
8w32r496w7k	4	1	the	the	DET
8w32r496w7k	4	2	pathophysiology	pathophysiology	NOUN
8w32r496w7k	4	3	of	of	ADP
8w32r496w7k	4	4	asthma	asthma	NOUN
8w32r496w7k	4	5	is	be	AUX
8w32r496w7k	4	6	typically	typically	ADV
8w32r496w7k	4	7	described	describe	VERB
8w32r496w7k	4	8	as	as	ADP
8w32r496w7k	4	9	chronic	chronic	ADJ
8w32r496w7k	4	10	inflammation	inflammation	NOUN
8w32r496w7k	4	11	in	in	ADP
8w32r496w7k	4	12	the	the	DET
8w32r496w7k	4	13	airways	airway	NOUN
8w32r496w7k	4	14	,	,	PUNCT
8w32r496w7k	4	15	dominated	dominate	VERB
8w32r496w7k	4	16	primarily	primarily	ADV
8w32r496w7k	4	17	by	by	ADP
8w32r496w7k	4	18	the	the	DET
8w32r496w7k	4	19	helper	helper	NOUN
8w32r496w7k	4	20	t	t	PROPN
8w32r496w7k	4	21	-	-	PUNCT
8w32r496w7k	4	22	cell	cell	NOUN
8w32r496w7k	4	23	2	2	NUM
8w32r496w7k	4	24	(	(	PUNCT
8w32r496w7k	4	25	th2	th2	NOUN
8w32r496w7k	4	26	)	)	PUNCT
8w32r496w7k	4	27	inflammatory	inflammatory	ADJ
8w32r496w7k	4	28	response	response	NOUN
8w32r496w7k	4	29	.	.	PUNCT
8w32r496w7k	5	1	this	this	DET
8w32r496w7k	5	2	response	response	NOUN
8w32r496w7k	5	3	is	be	AUX
8w32r496w7k	5	4	characterized	characterize	VERB
8w32r496w7k	5	5	by	by	ADP
8w32r496w7k	5	6	eosinophilic	eosinophilic	ADJ
8w32r496w7k	5	7	infiltration	infiltration	NOUN
8w32r496w7k	5	8	into	into	ADP
8w32r496w7k	5	9	the	the	DET
8w32r496w7k	5	10	airway	airway	NOUN
8w32r496w7k	5	11	smooth	smooth	ADJ
8w32r496w7k	5	12	muscle	muscle	NOUN
8w32r496w7k	5	13	cells	cell	NOUN
8w32r496w7k	5	14	but	but	CCONJ
8w32r496w7k	5	15	also	also	ADV
8w32r496w7k	5	16	mast	mast	NOUN
8w32r496w7k	5	17	cells	cell	NOUN
8w32r496w7k	5	18	,	,	PUNCT
8w32r496w7k	5	19	macrophages	macrophage	NOUN
8w32r496w7k	5	20	,	,	PUNCT
8w32r496w7k	5	21	plasma	plasma	NOUN
8w32r496w7k	5	22	cells	cell	NOUN
8w32r496w7k	5	23	,	,	PUNCT
8w32r496w7k	5	24	and	and	CCONJ
8w32r496w7k	5	25	neutrophils	neutrophil	NOUN
8w32r496w7k	5	26	may	may	AUX
8w32r496w7k	5	27	be	be	AUX
8w32r496w7k	5	28	present	present	ADJ
8w32r496w7k	5	29	(	(	PUNCT
8w32r496w7k	5	30	ref	ref	NOUN
8w32r496w7k	5	31	.	.	PUNCT
8w32r496w7k	6	1	1	1	X
8w32r496w7k	6	2	)	)	PUNCT
8w32r496w7k	6	3	.	.	PUNCT
8w32r496w7k	7	1	another	another	DET
8w32r496w7k	7	2	hallmark	hallmark	ADJ
8w32r496w7k	7	3	characteristic	characteristic	NOUN
8w32r496w7k	7	4	of	of	ADP
8w32r496w7k	7	5	asthma	asthma	NOUN
8w32r496w7k	7	6	is	be	AUX
8w32r496w7k	7	7	airway	airway	NOUN
8w32r496w7k	7	8	remodeling	remodeling	NOUN
8w32r496w7k	7	9	which	which	PRON
8w32r496w7k	7	10	encompasses	encompass	VERB
8w32r496w7k	7	11	structural	structural	ADJ
8w32r496w7k	7	12	changes	change	NOUN
8w32r496w7k	7	13	in	in	ADP
8w32r496w7k	7	14	the	the	DET
8w32r496w7k	7	15	airway	airway	NOUN
8w32r496w7k	7	16	wall	wall	NOUN
8w32r496w7k	7	17	as	as	ADP
8w32r496w7k	7	18	a	a	DET
8w32r496w7k	7	19	result	result	NOUN
8w32r496w7k	7	20	of	of	ADP
8w32r496w7k	7	21	lung	lung	NOUN
8w32r496w7k	7	22	responses	response	NOUN
8w32r496w7k	7	23	to	to	ADP
8w32r496w7k	7	24	damage	damage	NOUN
8w32r496w7k	7	25	from	from	ADP
8w32r496w7k	7	26	inflammatory	inflammatory	ADJ
8w32r496w7k	7	27	events	event	NOUN
8w32r496w7k	7	28	(	(	PUNCT
8w32r496w7k	7	29	ref	ref	VERB
8w32r496w7k	7	30	.	.	PUNCT
8w32r496w7k	7	31	1	1	X
8w32r496w7k	7	32	)	)	PUNCT
8w32r496w7k	7	33	.	.	PUNCT
8w32r496w7k	8	1	to	to	PART
8w32r496w7k	8	2	counter	counter	VERB
8w32r496w7k	8	3	these	these	DET
8w32r496w7k	8	4	effects	effect	NOUN
8w32r496w7k	8	5	,	,	PUNCT
8w32r496w7k	8	6	the	the	DET
8w32r496w7k	8	7	protein	protein	NOUN
8w32r496w7k	8	8	c	c	NOUN
8w32r496w7k	8	9	(	(	PUNCT
8w32r496w7k	8	10	pc	pc	NOUN
8w32r496w7k	8	11	)	)	PUNCT
8w32r496w7k	8	12	pathway	pathway	NOUN
8w32r496w7k	8	13	,	,	PUNCT
8w32r496w7k	8	14	intervenes	intervene	VERB
8w32r496w7k	8	15	by	by	ADP
8w32r496w7k	8	16	exerting	exert	VERB
8w32r496w7k	8	17	anti	anti	ADJ
8w32r496w7k	8	18	-	-	ADJ
8w32r496w7k	8	19	inflammatory	inflammatory	ADJ
8w32r496w7k	8	20	and	and	CCONJ
8w32r496w7k	8	21	anticoagulant	anticoagulant	ADJ
8w32r496w7k	8	22	effects	effect	NOUN
8w32r496w7k	8	23	.	.	PUNCT
8w32r496w7k	9	1	pc	pc	NOUN
8w32r496w7k	9	2	interacts	interact	VERB
8w32r496w7k	9	3	with	with	ADP
8w32r496w7k	9	4	endothelial	endothelial	ADJ
8w32r496w7k	9	5	cell	cell	NOUN
8w32r496w7k	9	6	protein	protein	NOUN
8w32r496w7k	9	7	c	c	NOUN
8w32r496w7k	9	8	receptor	receptor	NOUN
8w32r496w7k	9	9	(	(	PUNCT
8w32r496w7k	9	10	epcr	epcr	PROPN
8w32r496w7k	9	11	)	)	PUNCT
8w32r496w7k	9	12	which	which	PRON
8w32r496w7k	9	13	is	be	AUX
8w32r496w7k	9	14	an	an	DET
8w32r496w7k	9	15	endothelial	endothelial	ADJ
8w32r496w7k	9	16	transmembrane	transmembrane	NOUN
8w32r496w7k	9	17	glycoprotein	glycoprotein	NOUN
8w32r496w7k	9	18	that	that	PRON
8w32r496w7k	9	19	is	be	AUX
8w32r496w7k	9	20	expressed	express	VERB
8w32r496w7k	9	21	on	on	ADP
8w32r496w7k	9	22	the	the	DET
8w32r496w7k	9	23	luminal	luminal	ADJ
8w32r496w7k	9	24	surface	surface	NOUN
8w32r496w7k	9	25	of	of	ADP
8w32r496w7k	9	26	the	the	DET
8w32r496w7k	9	27	endothelium	endothelium	NOUN
8w32r496w7k	9	28	.	.	PUNCT
8w32r496w7k	10	1	when	when	SCONJ
8w32r496w7k	10	2	pc	pc	NOUN
8w32r496w7k	10	3	binds	bind	VERB
8w32r496w7k	10	4	to	to	ADP
8w32r496w7k	10	5	epcr	epcr	PROPN
8w32r496w7k	10	6	,	,	PUNCT
8w32r496w7k	10	7	it	it	PRON
8w32r496w7k	10	8	enhances	enhance	VERB
8w32r496w7k	10	9	the	the	DET
8w32r496w7k	10	10	activation	activation	NOUN
8w32r496w7k	10	11	of	of	ADP
8w32r496w7k	10	12	pc	pc	NOUN
8w32r496w7k	10	13	to	to	PART
8w32r496w7k	10	14	apc	apc	VERB
8w32r496w7k	10	15	by	by	ADP
8w32r496w7k	10	16	thrombin	thrombin	PROPN
8w32r496w7k	10	17	/	/	SYM
8w32r496w7k	10	18	thrombomodulin	thrombomodulin	PROPN
8w32r496w7k	10	19	,	,	PUNCT
8w32r496w7k	10	20	by	by	ADP
8w32r496w7k	10	21	at	at	ADV
8w32r496w7k	10	22	least	least	ADV
8w32r496w7k	10	23	20	20	NUM
8w32r496w7k	10	24	-	-	ADJ
8w32r496w7k	10	25	fold	fold	ADJ
8w32r496w7k	10	26	(	(	PUNCT
8w32r496w7k	10	27	ref	ref	NOUN
8w32r496w7k	10	28	.	.	PUNCT
8w32r496w7k	10	29	26	26	NUM
8w32r496w7k	10	30	)	)	PUNCT
8w32r496w7k	10	31	.	.	PUNCT
8w32r496w7k	11	1	therefore	therefore	ADV
8w32r496w7k	11	2	,	,	PUNCT
8w32r496w7k	11	3	it	it	PRON
8w32r496w7k	11	4	has	have	AUX
8w32r496w7k	11	5	been	be	AUX
8w32r496w7k	11	6	proposed	propose	VERB
8w32r496w7k	11	7	that	that	SCONJ
8w32r496w7k	11	8	epcr	epcr	PROPN
8w32r496w7k	11	9	may	may	AUX
8w32r496w7k	11	10	contribute	contribute	VERB
8w32r496w7k	11	11	to	to	ADP
8w32r496w7k	11	12	the	the	DET
8w32r496w7k	11	13	anti	anti	ADJ
8w32r496w7k	11	14	-	-	ADJ
8w32r496w7k	11	15	inflammatory	inflammatory	ADJ
8w32r496w7k	11	16	effects	effect	NOUN
8w32r496w7k	11	17	of	of	ADP
8w32r496w7k	11	18	apc	apc	NOUN
8w32r496w7k	11	19	.	.	PUNCT
8w32r496w7k	12	1	the	the	DET
8w32r496w7k	12	2	current	current	ADJ
8w32r496w7k	12	3	study	study	NOUN
8w32r496w7k	12	4	examined	examine	VERB
8w32r496w7k	12	5	the	the	DET
8w32r496w7k	12	6	role	role	NOUN
8w32r496w7k	12	7	of	of	ADP
8w32r496w7k	12	8	epcr	epcr	NOUN
8w32r496w7k	12	9	in	in	ADP
8w32r496w7k	12	10	mice	mouse	NOUN
8w32r496w7k	12	11	challenged	challenge	VERB
8w32r496w7k	12	12	with	with	ADP
8w32r496w7k	12	13	the	the	DET
8w32r496w7k	12	14	inflammatory	inflammatory	ADJ
8w32r496w7k	12	15	agent	agent	NOUN
8w32r496w7k	12	16	ovalbumin	ovalbumin	NOUN
8w32r496w7k	12	17	(	(	PUNCT
8w32r496w7k	12	18	ova	ova	NOUN
8w32r496w7k	12	19	)	)	PUNCT
8w32r496w7k	12	20	.	.	PUNCT
8w32r496w7k	13	1	epcrì_å«/ì_å	epcrì_å«/ì_å	X
8w32r496w7k	13	2	«	«	PUNCT
8w32r496w7k	13	3	(	(	PUNCT
8w32r496w7k	13	4	epcr	epcr	ADV
8w32r496w7k	13	5	very	very	ADV
8w32r496w7k	13	6	low	low	ADV
8w32r496w7k	13	7	-	-	PUNCT
8w32r496w7k	13	8	expressing	express	VERB
8w32r496w7k	13	9	mice	mouse	NOUN
8w32r496w7k	13	10	)	)	PUNCT
8w32r496w7k	13	11	and	and	CCONJ
8w32r496w7k	13	12	wild	wild	ADJ
8w32r496w7k	13	13	-	-	PUNCT
8w32r496w7k	13	14	type	type	NOUN
8w32r496w7k	13	15	(	(	PUNCT
8w32r496w7k	13	16	wt	wt	PROPN
8w32r496w7k	13	17	)	)	PUNCT
8w32r496w7k	13	18	mice	mouse	NOUN
8w32r496w7k	13	19	were	be	AUX
8w32r496w7k	13	20	utilized	utilize	VERB
8w32r496w7k	13	21	for	for	ADP
8w32r496w7k	13	22	this	this	DET
8w32r496w7k	13	23	study	study	NOUN
8w32r496w7k	13	24	.	.	PUNCT
8w32r496w7k	14	1	while	while	SCONJ
8w32r496w7k	14	2	the	the	DET
8w32r496w7k	14	3	airway	airway	NOUN
8w32r496w7k	14	4	hyperresponsiveness	hyperresponsiveness	NOUN
8w32r496w7k	14	5	to	to	ADP
8w32r496w7k	14	6	ova	ova	NOUN
8w32r496w7k	14	7	challenge	challenge	NOUN
8w32r496w7k	14	8	in	in	ADP
8w32r496w7k	14	9	wt	wt	PROPN
8w32r496w7k	14	10	and	and	CCONJ
8w32r496w7k	14	11	epcrì_å«/ì_å	epcrì_å«/ì_å	X
8w32r496w7k	14	12	«	«	VERB
8w32r496w7k	14	13	mice	mouse	NOUN
8w32r496w7k	14	14	were	be	AUX
8w32r496w7k	14	15	similiar	similiar	ADJ
8w32r496w7k	14	16	,	,	PUNCT
8w32r496w7k	14	17	examination	examination	NOUN
8w32r496w7k	14	18	of	of	ADP
8w32r496w7k	14	19	bronchioalveolar	bronchioalveolar	ADJ
8w32r496w7k	14	20	lavage	lavage	NOUN
8w32r496w7k	14	21	fluid	fluid	NOUN
8w32r496w7k	14	22	(	(	PUNCT
8w32r496w7k	14	23	balf	balf	NOUN
8w32r496w7k	14	24	)	)	PUNCT
8w32r496w7k	14	25	,	,	PUNCT
8w32r496w7k	14	26	lung	lung	NOUN
8w32r496w7k	14	27	tissue	tissue	NOUN
8w32r496w7k	14	28	,	,	PUNCT
8w32r496w7k	14	29	and	and	CCONJ
8w32r496w7k	14	30	circulating	circulate	VERB
8w32r496w7k	14	31	blood	blood	NOUN
8w32r496w7k	14	32	showed	show	VERB
8w32r496w7k	14	33	significantly	significantly	ADV
8w32r496w7k	14	34	higher	high	ADJ
8w32r496w7k	14	35	levels	level	NOUN
8w32r496w7k	14	36	of	of	ADP
8w32r496w7k	14	37	eosinophils	eosinophil	NOUN
8w32r496w7k	14	38	in	in	ADP
8w32r496w7k	14	39	epcrì_å«/ì_å	epcrì_å«/ì_å	SPACE
8w32r496w7k	14	40	«	«	X
8w32r496w7k	14	41	mice	mouse	NOUN
8w32r496w7k	14	42	versus	versus	ADP
8w32r496w7k	14	43	wt	wt	NOUN
8w32r496w7k	14	44	mice	mouse	NOUN
8w32r496w7k	14	45	,	,	PUNCT
8w32r496w7k	14	46	and	and	CCONJ
8w32r496w7k	14	47	significantly	significantly	ADV
8w32r496w7k	14	48	higher	high	ADJ
8w32r496w7k	14	49	levels	level	NOUN
8w32r496w7k	14	50	of	of	ADP
8w32r496w7k	14	51	eotaxin	eotaxin	PROPN
8w32r496w7k	14	52	and	and	CCONJ
8w32r496w7k	14	53	interleukin-13	interleukin-13	PROPN
8w32r496w7k	14	54	.	.	PUNCT
8w32r496w7k	15	1	the	the	DET
8w32r496w7k	15	2	th2	th2	ADJ
8w32r496w7k	15	3	cell	cell	NOUN
8w32r496w7k	15	4	response	response	NOUN
8w32r496w7k	15	5	from	from	ADP
8w32r496w7k	15	6	isolated	isolated	ADJ
8w32r496w7k	15	7	peribronchial	peribronchial	ADJ
8w32r496w7k	15	8	lymph	lymph	NOUN
8w32r496w7k	15	9	nodes	node	NOUN
8w32r496w7k	15	10	in	in	ADP
8w32r496w7k	15	11	epcrì_å«/ì_å	epcrì_å«/ì_å	SPACE
8w32r496w7k	15	12	«	«	X
8w32r496w7k	15	13	mice	mouse	NOUN
8w32r496w7k	15	14	showed	show	VERB
8w32r496w7k	15	15	significantly	significantly	ADV
8w32r496w7k	15	16	elevated	elevate	VERB
8w32r496w7k	15	17	interleukin-5	interleukin-5	PROPN
8w32r496w7k	15	18	levels	level	NOUN
8w32r496w7k	15	19	.	.	PUNCT
8w32r496w7k	16	1	bronchial	bronchial	ADJ
8w32r496w7k	16	2	epithelial	epithelial	ADJ
8w32r496w7k	16	3	cell	cell	NOUN
8w32r496w7k	16	4	adenovirus-12	adenovirus-12	NOUN
8w32r496w7k	16	5	sv40	sv40	PROPN
8w32r496w7k	16	6	hybrid	hybrid	ADJ
8w32r496w7k	16	7	virus	virus	NOUN
8w32r496w7k	16	8	transformed	transform	VERB
8w32r496w7k	16	9	cells	cell	NOUN
8w32r496w7k	16	10	(	(	PUNCT
8w32r496w7k	16	11	beas-2b	beas-2b	SPACE
8w32r496w7k	16	12	)	)	PUNCT
8w32r496w7k	16	13	,	,	PUNCT
8w32r496w7k	16	14	a	a	DET
8w32r496w7k	16	15	human	human	ADJ
8w32r496w7k	16	16	epithelial	epithelial	ADJ
8w32r496w7k	16	17	cell	cell	NOUN
8w32r496w7k	16	18	line	line	NOUN
8w32r496w7k	16	19	,	,	PUNCT
8w32r496w7k	16	20	when	when	SCONJ
8w32r496w7k	16	21	stimulated	stimulate	VERB
8w32r496w7k	16	22	with	with	ADP
8w32r496w7k	16	23	balf	balf	NOUN
8w32r496w7k	16	24	from	from	ADP
8w32r496w7k	16	25	wt	wt	PROPN
8w32r496w7k	16	26	and	and	CCONJ
8w32r496w7k	16	27	epcrì_å«/ì_å	epcrì_å«/ì_å	NOUN
8w32r496w7k	16	28	«	«	VERB
8w32r496w7k	16	29	mice	mouse	NOUN
8w32r496w7k	16	30	,	,	PUNCT
8w32r496w7k	16	31	showed	show	VERB
8w32r496w7k	16	32	higher	high	ADJ
8w32r496w7k	16	33	eotaxin	eotaxin	PROPN
8w32r496w7k	16	34	message	message	NOUN
8w32r496w7k	16	35	ribonucleic	ribonucleic	ADJ
8w32r496w7k	16	36	acid	acid	NOUN
8w32r496w7k	16	37	(	(	PUNCT
8w32r496w7k	16	38	mrna	mrna	PROPN
8w32r496w7k	16	39	)	)	PUNCT
8w32r496w7k	16	40	production	production	NOUN
8w32r496w7k	16	41	in	in	ADP
8w32r496w7k	16	42	the	the	DET
8w32r496w7k	16	43	epcrì_å«/ì_å	epcrì_å«/ì_å	NOUN
8w32r496w7k	16	44	«	«	PUNCT
8w32r496w7k	16	45	mice	mouse	NOUN
8w32r496w7k	16	46	.	.	PUNCT
8w32r496w7k	17	1	results	result	NOUN
8w32r496w7k	17	2	from	from	ADP
8w32r496w7k	17	3	this	this	DET
8w32r496w7k	17	4	study	study	NOUN
8w32r496w7k	17	5	indicate	indicate	VERB
8w32r496w7k	17	6	that	that	SCONJ
8w32r496w7k	17	7	a	a	DET
8w32r496w7k	17	8	deficiency	deficiency	NOUN
8w32r496w7k	17	9	in	in	ADP
8w32r496w7k	17	10	epcr	epcr	PROPN
8w32r496w7k	17	11	increases	increase	VERB
8w32r496w7k	17	12	the	the	DET
8w32r496w7k	17	13	inflammatory	inflammatory	ADJ
8w32r496w7k	17	14	response	response	NOUN
8w32r496w7k	17	15	in	in	ADP
8w32r496w7k	17	16	a	a	DET
8w32r496w7k	17	17	murine	murine	NOUN
8w32r496w7k	17	18	model	model	NOUN
8w32r496w7k	17	19	of	of	ADP
8w32r496w7k	17	20	ova	ova	PROPN
8w32r496w7k	17	21	-	-	PUNCT
8w32r496w7k	17	22	induced	induce	VERB
8w32r496w7k	17	23	asthma	asthma	NOUN
8w32r496w7k	17	24	.	.	PUNCT